Pro-atherogenic monocytes as risk predictor for severe coronary artery disease in post-menopausal women
Authors:
- 9 August 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (5) , 791-793
Abstract
No abstract availableKeywords
Funding Information
- Research Commission of the Medical Faculty of the Heinrich Heine University (29-2019)
- German Research Foundation
- German Heart Foundation
- Otto-Hess Funding
- German Cardiac Society
This publication has 8 references indexed in Scilit:
- Phenotypic and functional alterations of monocyte subsets with agingImmunity & Ageing, 2022
- Men Have a Stronger Monocyte-Derived Cytokine Production Response upon Stimulation with the Gram-Negative Stimulus Lipopolysaccharide than Women: A Pooled Analysis Including 15 Study PopulationsJournal of Innate Immunity, 2019
- Nonclassical Monocytes in Health and DiseaseAnnual Review of Immunology, 2019
- Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individualsAging, 2018
- Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery diseaseAtherosclerosis, 2016
- Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findingsAtherosclerosis, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002